CAS 105816-04-4: Nateglinide
Description:Nateglinide is an oral hypoglycemic agent primarily used in the management of type 2 diabetes mellitus. It belongs to the class of medications known as meglitinides, which stimulate insulin secretion from the pancreas in response to meals, thereby helping to control postprandial blood glucose levels. The chemical formula of nateglinide is C19H28N2O4S, and it features a unique structure that includes a sulfonamide group, which is integral to its mechanism of action. Nateglinide is characterized by its rapid onset and short duration of action, making it particularly effective for controlling blood sugar spikes after meals. It is typically administered shortly before meals and is often used in conjunction with other antidiabetic medications. Common side effects may include hypoglycemia, gastrointestinal disturbances, and weight gain. As with any medication, it is essential for patients to consult healthcare professionals for personalized advice and monitoring while using nateglinide.
Formula:C19H27NO3
InChI:InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1
InChI key:InChIKey=OELFLUMRDSZNSF-BRWVUGGUSA-N
SMILES:O=C(O)C(NC(=O)C1CCC(CC1)C(C)C)CC=2C=CC=CC2
- Synonyms:
- AY 4166
- N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
- D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
- D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-
- A 4166
